Boothbay Fund Management’s ProMIS Neurosciences PMN Stock Holding History
Bought
Maintained
Sold
Other funds holding PMN
YF
6CM
Boothbay Fund Management's PMN Position: Q3 2026 in Review
Boothbay Fund Management held its ProMIS Neurosciences (PMN) position steady in Q3 2026 at 62,078 shares worth $674K. The position accounts for 0.01% of the portfolio, ranked #1192.
Boothbay Fund Management first reported a position in PMN in Q1 2026 and has held it in 3 quarters since. The position peaked at $817K in Q2 2026. 31 funds tracked by Wall St. Rank hold PMN as of Q3 2026.
- Boothbay Fund Management held 62,078 shares of ProMIS Neurosciences worth $674K as of Q3 2026.
- Boothbay Fund Management left its ProMIS Neurosciences share count unchanged in Q3 2026.
- ProMIS Neurosciences made up 0.01% of Boothbay Fund Management's portfolio in Q3 2026, its #1192 holding.
- Boothbay Fund Management first reported a position in ProMIS Neurosciences in Q1 2026 and has held it in 3 quarters since.
- Boothbay Fund Management's ProMIS Neurosciences position peaked at $817K in Q2 2026.
- 31 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.